| 05-Feb-2025 |
7NR Retail Ltd |
7NR Retail Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve To consider and approve the Un-Audited Financial Results of the Company for the quarter and nine months ended as on 31st December 2024 along with Limited Review Report thereon.
b) To consider and take note of Resignation of Mr. Tarachand Gangasahay Agrawal (DIN00465635) as Managing Director of the Company with effect from closure of working hours of 5th February 2025.
c) To appoint Mr. Chetan Kumar Ojha (DIN: 09706197) as an Additional Executive Director of the company with effect from 5th February 2025.
d) To appoint Mr. Chetan Kumar Ojha (DIN: 09706197) as Managing Director of the Company for a period of 5 years Subject to the regularisation in Extra-Ordinary General Meeting and approval of shareholders in the Extra-Ordinary General Meeting with effect from the date of Extra-Ordinary General Meeting.
e) To transact other businesses as per agenda being circulated |
| 05-Feb-2025 |
Shree Ganesh Rem |
Shree Ganesh Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve the Unaudited Financial Results for the quarter and nine months ended December 31 2024 |
| 05-Feb-2025 |
H.G. Infra Engg. |
H.G. Infra Engineering Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and nine months ended December 31 2024. |
| 05-Feb-2025 |
Inventurus Knowl |
Inventurus Knowledge Solutions Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve the unaudited standalone and consolidated financial results of the Company for the quarter and period ended December 31 2024.
Further in continuation of our earlier letter dated December 27 2024 under subject Intimation of closure of Trading Window and in terms of the Companys Code of Conduct to Regulate Monitor and Report Trading by Designated Persons and SEBI (Prohibition of Insider Trading) Regulations 2015 the Trading Window for dealing in the securities of the Company by the Designated Persons of the Company and/or their immediate relatives shall remain closed from January 1 2025 till February 7 2025 (both days inclusive) for the purpose of said financial results. |
| 05-Feb-2025 |
Medico Remedies |
Medico Remedies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/02/2025 inter alia to consider and approve Unaudited Financial Results for the Quarter and Nine months ended 31st December 2024 along with the Limited Review Report thereon; |